Table 3.
Control group, M (SE) | MF group, M (SE) | MF vs. control | |
---|---|---|---|
Baseline, g/dL | 13.65 (0.24) | 12.93 (0.23) | −0.72 (0.33), p = 0.03** |
Change at 1 month post tx | −0.88 (0.18) | −0.43 (0.18) | p = 0.08** |
% | −6.5% | −3.3% | |
p-value | <0.0001* | 0.02* | |
Change at 6 months post tx | −0.54 (0.17) | −0.24 (0.20) | p = 0.26** |
% | −4% | −1.9% | |
p-value | 0.002* | 0.22* | |
Change at 12 months post tx | −0.18 (0.17) | −0.12 (0.16) | p = 0.82** |
% | −1.3% | −0.9% | |
p-value | 0.3* | 0.45* |
Statistically significant differences (p < 0.05) are noted in bold.
Represents the comparison performed between the value at a specific time point and the baseline value.
Represents the comparison performed between the control and the metformin group at each specific time point.